Competitive Advantages for SLI-F06
Competitive Advantages for SLI-F06
For Acute Wound Healing
- SLI-F06 minimizes scarring by improving cell migration and contraction to promote faster tissue healing, decreased scar size, and improved wound tensile strength.
- SLI-F06 can be produced synthetically with a market-viable cost of goods.
- SLI-F06 has been shown to be safe in animal studies and a Phase 1/2a human clinical study.
- The Phase 1/2a study demonstrated efficacy in both abdominoplasty and biopsy models.
- SLI-F06 is now poised to move into Phase 2b with two separate studies: acute scar abdominoplasty and scar revision.
For Diabetic Wound Healing
- SLI-F06 stimulates diabetic fibroblast migration and myofibroblast activation, accelerating the healing of diabetic wounds.
- SLI-F06 has been shown to enhance diabetic wound healing in both rodent and porcine models.
